A comprehensive strategy that combines pharmacological advances, vector control, public outreach to raise awareness and ...
CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars: On January 30, 2025, the European Medicines Agency (EMA) Committee ...
The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on X, opting instead to utilize rival platform Bluesky.
As such, the tech giant is conducting a limited test of ads on Threads with a small number of advertisers, allowing them to ...
The European Medicines Agency (EMA) has joined the hordes of users abandoning Elon Musk's X.com (formerly Twitter) and will ...
The government agency says X no longer suits its communication needs.
The European Medicines Agency (EMA) has decided to stop using the social media platform X due to content concerns and will instead use Bluesky. This move aligns with other organizations stepping back ...
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...
The European Medicines Agency (EMA), which is the regulator for vaccines and ... The agency will publish on the alternative website Bluesky from now on. The X account will not be deleted. The agency ...
The British Chamber of Commerce (BCC) told Sky News they would support the move, saying their research "indicates it would have majority support among UK businesses who trade in the European region".
Simply sign up to the European banks myFT Digest -- delivered directly to your inbox. European banks are on course to return close to €123bn to shareholders for the second consecutive year as ...
We had an account briefly on Bluesky but the league asked us to take it down because it’s not an approved social media platform for the NFL yet.” There’s been no explanation from the NFL on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results